Anti-Human APP Abeta Recombinant Antibody(Solanezumab)
-
产品编号
YR1197
-
别名
科研级 Solanezumab ( 苏兰组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1197 |
| Alias | 科研级 Solanezumab ( 苏兰组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab |
| Size | 1mg, 5mg |
| Molecular Name | Solanezumab |
| CAS Number | 955085-14-0 |
| Target | APP Abeta[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Solanezumab (proposed INN, LY2062430[1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector[2] for patients with Alzheimer's disease.[3][4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.[5] |
| Application | WB, FuncS, IF, Neut, ELISA, FCM, IP |
| Remarks | This product is for research use only. |
0